RSV immunisation: lessons from the COVID-19 pandemic
- PMID: 36634693
- DOI: 10.1016/S2352-4642(22)00377-7
RSV immunisation: lessons from the COVID-19 pandemic
Conflict of interest statement
LB is the founding chairman of the ReSViNET Foundation. M-NB declares no competing interests.
Comment on
-
Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort study.Lancet Child Adolesc Health. 2023 Mar;7(3):171-179. doi: 10.1016/S2352-4642(22)00371-6. Epub 2023 Jan 9. Lancet Child Adolesc Health. 2023. PMID: 36634692 Free PMC article.
-
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.Lancet Child Adolesc Health. 2023 Mar;7(3):180-189. doi: 10.1016/S2352-4642(22)00321-2. Epub 2023 Jan 9. Lancet Child Adolesc Health. 2023. PMID: 36634694 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical